EU to set new biosimilar drug rules by mid-year
by on Jan.07, 2012, under Health and Fitness
LONDON (Reuters) – European regulators will detail the requirements for copies of multiple types of biotech drugs by mid-2012, setting the stage for increased generic competition in a multibillion-dollar market that includes products for cancer an…
View full post on Yahoo! Health News
